Clinical Trials Directory

Trials / Completed

CompletedNCT00718653

Effects of Antioxidants on Human Macular Pigments

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
National Eye Institute (NEI) · NIH
Sex
All
Age
50 Years – 70 Years
Healthy volunteers
Accepted

Summary

Age-related macular degeneration (AMD) is the leading cause of blindness in the United States. Low dietary intake or low blood levels of lutein and zeaxanthin, which are the only pigments found in the macular region of the human retina, has been associated with an increased risk for AMD. We have reported that the dietary supplementation of lutein and zeaxanthin can increase the macular pigments (MP) of the eye. MP effectively absorbs blue light as well as quenches reactive oxygen species (ROS). Green tea polyphenols are also effective scavenger of ROS in vitro. Our goal is to elucidate how to effectively increase MP by physiologic levels of antioxidant supplementation. We hypothesize that lutein and tea polyphenols protect the macula of the eye by increasing MP carotenoids effectively through an antioxidant mechanism.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLuteinLutein (12 mg/d)
DIETARY_SUPPLEMENTLutein plus green tea extractlutein (12 mg/d) plus green tea extract (200 mg/d)

Timeline

Start date
2004-09-01
Primary completion
2007-12-01
Completion
2007-12-01
First posted
2008-07-21
Last updated
2009-03-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00718653. Inclusion in this directory is not an endorsement.